Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer
isPeerReviewed
numberOfPages
abstract
<p>PURPOSE: Although cyclin-de ...... rapy in ER+ breast cancer.</p>
@en
authorList
type
label
Dual Targeting of CDK4/6 and B ...... eceptor-Positive Breast Cancer
category
electronicVersions
externalOrganisations
journalAssociation
journalNumber
language
managingOrganisationalUnit
openAccessPermission
organisationalUnits
publicationStatuses
submissionYear
totalScopusCitations
visibility
Publiek - Geen beperking
@nl
workflow
Validated
@en
author
datePublished
2020-08-01